Adenoviral gene transfer of hepatic stimulator substance confers resistance against hepatic ischemia-reperfusion injury by improving mitochondrial function

Human Gene Therapy

Volumn 24, Issue 4, 2013, Pages 443-456

  Jiang, Shu Jun ^a   Li, Wen ^a   An, Wei ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYTOCHROME C; GROWTH PROMOTOR; HEPATIC STIMULATOR SUBSTANCE; LIVER PROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CLINICAL PRACTICE; CONTROLLED STUDY; GENE TRANSFER; HYPOXIA; LIVER FUNCTION; LIVER INJURY; LIVER ISCHEMIA; LIVER RESECTION; LIVER TRANSPLANTATION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; NONHUMAN; REOXYGENATION; REPERFUSION; RESPIRATORY CHAIN; ULTRASTRUCTURE;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL SURVIVAL; HUMANS; LIVER; MALE; MICE; MITOCHONDRIA, LIVER; PEPTIDES; REPERFUSION INJURY; TRANSFECTION;

MUS;

EID: 84876544200     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2012.219     Document Type: Article

References (37)

1. Abe, Y., Hines, I.N., Zibari, G., et al. (2009). Mouse model of liver ischemia and reperfusion injury: Method for studying reactive oxygen and nitrogen metabolites in vivo. Free Radic. Biol. Med. 46, 1-7.
2. Cao, Y., Fu, Y.L., Yu, M., et al. (2009). Human augmenter of liver regeneration is important for hepatoma cell viability and resistance to radiation-induced oxidative stress. Free Radic. Biol. Med. 47, 1057-1066.
3. Daithankar, V.N., Wang, W., Trujillo, J.R., et al. (2012). Flavin-linked Erv-family sulfhydryl oxidases release superoxide anion during catalytic turnover. Biochemistry 51, 265-272.
4. Dayoub, R., Wagner, H., Bataille, F., et al. (2011). Liver regeneration associated protein (ALR) exhibits antimeta-static potential in hepatocellular carcinoma. Mol. Med. 17, 221-228.
5. Georgiev, P., Dahm, F., Graf, R., et al. (2006). Blocking the path to death: Anti-apoptotic molecules in ischemia/reperfusion injury of the liver. Curr. Pharm. Des. 12, 2911-2921.
6. Giorda, R., Hagiya, M., Seki, T., et al. (1996). Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene. Mol. Med. 2, 97-108.
7. Gribilas, G., Zarros, A., Zira, A., et al. (2009). Involvement of hepatic stimulator substance in experimentally induced fi-brosis and cirrhosis in the rat. Dig. Dis. Sci. 54, 2367-2376.
8. shc ablation: Up-regulation of anti-oxidant and anti-apoptotic proteins. J. He-patol. 48, 422-432.
9. Hagiya, M., Francavilla, A., Polimeno, L., et al. (1995). Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: Expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc. Natl. Acad. Sci. U.S.A. 92, 3076.
10. He, F., Wu, C., Tu, Q., et al. (1993). Human hepatic stimulator substance: A product of gene expression of human fetal liver tissue. Hepatology 17, 225-229.
11. Ho, D.W., Fan, S.T., To, J., et al. (2002). Selective plasma filtration for treatment of fulminant hepatic failure induced by d-ga-lactosamine in a pig model. Gut 50, 869-876.
12. Hofhaus, G., Stein, G., Polimeno, L., et al. (1999). Highly divergent amino termini of the homologous human ALR and yeast scERV1 gene products define species specific differences in cellular localization. Eur. J. Cell. Biol. 78, 349-356.
13. Jaeschke, H. (2003a). Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am. J. Physiol. Gas-trointest. Liver Physiol. 284, G15-G26.
14. Jaeschke, H. (2003b). Role of reactive oxygen species in hepatic ischemia-reperfusion injury and preconditioning. J. Invest. Surg. 16, 127-140.
15. Jaeschke, H., and Lemasters, J.J. (2003). Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastro-enterology 125, 1246-1257.
16. Kim, J.S., He, L., Qian, T., et al. (2003). Role of the mitochondrial permeability transition in apoptotic and necrotic death after ischemia/reperfusion injury to hepatocytes. Curr. Mol. Med. 3, 527-535.
17. Klune, J.R., and Tsung, A. (2010). Molecular biology of liver ischemia/reperfusion injury: Established mechanisms and recent advancements. Surg. Clin. North. Am. 90, 665-677.
18. LaBrecque, D.R., and Pesch, L.A. (1975). Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver. J. Physiol. 248, 273-284.
19. LaBrecque, D.R., Steele, G., Fogerty, S., et al. (1987). Purification and physical-chemical characterization of hepatic stimulator substance. Hepatology 7, 100-106.
20. Li, C., and Jackson, R.M. (2002). Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol. Cell. Physiol. 282, C227-C241.
21. Li, S., Tang, Z., Yu, H., et al. (2011). Administration of naked plasmid encoding hepatic stimulator substance by hydrody-namic tail vein injection protects mice from hepatic failure by suppressing the mitochondrial permeability transition. J. Pharmacol. Exp. Ther. 338, 750-757.
22. 2-induced cell apoptosis. FEBS Lett. 584, 3929-3935.
23. Liao, X.H., Zhang, L., Liu, Q., et al. (2010). Augmenter of liver regeneration protects kidneys from ischaemia/reperfusion injury in rats. Nephrol. Dial. Transplant. 25, 2921-2929.
24. Liatsos, G.D., Mykoniatis, M.G., Margeli, A., et al. (2003). Effect of acute ethanol exposure on hepatic stimulator substance (HSS) levels during liver regeneration: Protective function of HSS. Dig. Dis. Sci. 48, 1929-1938.
25. McConnell, M.J., and Imperiale, M.J. (2004). Biology of adeno-virus and its use as a vector for gene therapy. Hum. Gene. Ther. 15, 1022-1033.
26. Mei, M.H., An, W., Zhang, B.H., et al. (1993). Hepatic stimulator substance protects against acute liver failure induced by carbon tetrachloride poisoning in mice. Hepatology 17, 638-644.
27. Mukhopadhyay, P., Horvath, B., Zsengeller, Z., et al. (2012). Mi-tochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: Therapeutic potential of mitochondrially targeted antioxidants. Free. Radic. Biol. Med. 53, 1123-1138.
28. Pawlowski, R., and Jura, J. (2006). ALR and liver regeneration. Mol. Cell. Biochem. 288, 159-169.
29. Polimeno, L., Capuano, F., Marangi, L.C., et al. (2000). The augmenter of liver regeneration induces mitochondrial gene expression in rat liver and enhances oxidative phosphorylation capacity of liver mitochondria. Dig. Liver Dis. 32, 510-517.
30. Serviddio, G., Bellanti, F., Sastre, J., et al. (2010). Targeting mitochondria: A new promising approach for the treatment of liver diseases. Curr. Med. Chem. 17, 2325-2337.
31. Thasler, W.E., Schlott, T., Thelen, P., et al. (2005). Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma. Histopathology 47, 57-66.
32. Thirunavukkarasu, C., Wang, L.F., Harvey, S.A., et al. (2008). Augmenter of liver regeneration: An important intracellular survival factor for hepatocytes. J. Hepatol. 48, 578-588.
33. Wang, W., Winther, J.R., and Thorpe, C. (2007). Erv2p: Characterization of the redox behavior of a yeast sulfhydryl oxi-dase. Biochemistry 46, 3246-3254.
34. Weinberg, J.M., Venkatachalam, M.A., Roeser, N.F., et al. (2000). Mitochondrial dysfunction during hypoxia/reox-ygenation and its correction by anaerobic metabolism of citric acid cycle intermediates. Proc. Natl. Acad. Sci. U.S.A. 97, 2826-2831.
35. Wu, C.K., Dailey, T.A., Dailey, H.A., et al. (2003). The crystal structure of augmenter of liver regeneration: A mammalian FAD-dependent sulfhydryl oxidase. Protein Sci. 12, 1109-1118.
36. 2-induced cell apoptosis via preservation of mitochondria. Arch. Biochem. Biophys. 464, 48-56.
37. Wu, Y., Zhang, J., Dong, L., et al. (2010). Hepatic stimulator substance mitigates hepatic cell injury through suppression of the mitochondrial permeability transition. FEBS J. 277, 1297-1309.